t-butyl [2-(2-{[methyl(5,6,7,8-tetrahydro-8-quinolinyl)amino]methyl}-1H-benzimidazol-1-yl)ethyl]carbamate | 876589-45-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: t-butyl [2-(2-{[methyl(5,6,7,8-tetrahydro-8-quinolinyl)amino]methyl}-1H-benzimidazol-1-yl)ethyl]carbamate
• 英文别名: tert-butyl N-[2-[2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]benzimidazol-1-yl]ethyl]carbamate
• CAS: 876589-45-6
• 化学式: C₂₅H₃₃N₅O₂
• 分子量: 435.569
• InChiKey: PJVGOHOBXRHDHN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  32
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  72.3
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  t-butyl [2-(2-{[methyl(5,6,7,8-tetrahydro-8-quinolinyl)amino]methyl}-1H-benzimidazol-1-yl)ethyl]carbamate 在 盐酸 作用下， 以 1,4-二氧六环 、 甲醇 为溶剂， 反应 2.0h， 以55%的产率得到N-{[1-(2-aminoethyl)-1H-benzimidazol-2-yl]methyl}-N-methyl-5,6,7,8-tetrahydro-8-quinolinamine hydrochloride
  参考文献：
  名称：

  [EN] CHEMICAL COMPOUNDS
  [FR] COMPOSES CHIMIQUES

  摘要：

  本发明提供了一种新型化合物，表现出对目标细胞免受HIV感染的保护效果，其特异地结合趋化因子受体，并影响自然配体或趋化因子与目标细胞的受体（如CXCR4和/或CCR5）的结合。

  公开号：

  WO2006020415A1
• 作为产物：
  描述：

  N-((1H-benzimidazol-2-yl)methyl)-N-methyl-5,6,7,8-tetrahydroquinoline-8-amine 、 N-Boc-2-氯乙胺 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 t-butyl [2-(2-{[methyl(5,6,7,8-tetrahydro-8-quinolinyl)amino]methyl}-1H-benzimidazol-1-yl)ethyl]carbamate
  参考文献：
  名称：

  Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1

  摘要：

  Several novel amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines were synthesized which had potent activity against HIV-1. The synthetic approaches adopted allowed for variation of the substitution pattern and resulting changes in antiviral activity are highlighted. This led to the identification of compounds with low and sub-nanomolar anti-HIV-1 activity. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.07.037

文献信息

• Chemical Compounds
  申请人：Gudmundsson Kristjan

  公开号：US20080096861A1

  公开（公告）日：2008-04-24

  The present invention provides compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 of a target cell.

  本发明提供了一种化合物，它以结合趋化因子受体的方式对目标细胞表现出对HIV感染的保护作用，并且影响天然配体或趋化因子与目标细胞的CXCR4等受体的结合。
• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSES CHIMIQUES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2006020415A1

  公开（公告）日：2006-02-23

  The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 and/or CCR5 of a target cell.

  本发明提供了一种新型化合物，表现出对目标细胞免受HIV感染的保护效果，其特异地结合趋化因子受体，并影响自然配体或趋化因子与目标细胞的受体（如CXCR4和/或CCR5）的结合。
• Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1
  作者：Kristjan S. Gudmundsson、Paul R. Sebahar、Leah D’Aurora Richardson、John F. Miller、Elizabeth M. Turner、John G. Catalano、Andrew Spaltenstein、Wendell Lawrence、Michael Thomson、Stephen Jenkinson

  DOI：10.1016/j.bmcl.2009.07.037

  日期：2009.9

  Several novel amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines were synthesized which had potent activity against HIV-1. The synthetic approaches adopted allowed for variation of the substitution pattern and resulting changes in antiviral activity are highlighted. This led to the identification of compounds with low and sub-nanomolar anti-HIV-1 activity. (C) 2009 Elsevier Ltd. All rights reserved.